Process validation demonstrates that production processes consistently yield devices that meet required quality, safety and performance – especially where results cannot be fully verified by subsequent inspection and test.
About this Whitepaper
This whitepaper provides a practical guide to planning and executing manufacturing process validation under the European regulatory framework. It explains how to align EU MDR 2017/745 and IVDR 2017/746 with EN ISO 13485:2016 and EN ISO 14971, ensuring compliance while strengthening quality systems.
You will learn:
- When to validate vs. verify, using EN ISO 13485:2016, FDA 21 CFR 820.75/QMSR, and GHTF/SG3/N99-10 guidance.
- The lifecycle approach: Process Design, Process Performance Qualification (PPQ), and Ongoing Process Verification.
- How to define Critical Quality Attributes (CQAs) and Critical Process Parameters (CPPs) and establish robust control strategies.
- Validation requirements for sterilization and packaging processes, including ISO 11135, ISO 11137-1, EN ISO 25424, and ISO 11607-2.
- Essential documentation: PPQ protocols, statistical sampling rationales, and validation reports.
- Change control, revalidation triggers, and common audit deficiencies to avoid.
Download the Whitepaper below.
View our other resources and company news
Guide Practical Guide to Post-Market Surveillance (PMS) under EU MDR/IVDR
The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Blog AI for Pharmaceutical SOPs: Transforming Quality Management and Compliance
Rephine helps pharmaceutical and biotech companies transition to digital QMS platforms like Veeva Vault, MasterControl, or TrackWise. From vendor-neutral selection to full GxP-compliant validation and ...
Read More
CAPA Strengthening CAPA & Exceptions Management
Learn how Rephine’s tailored GxP training helped a pharmaceutical manufacturer strengthen CAPA effectiveness, improve compliance, and boost team confidence.
Read More
Blog EU GMP Annex 1 vs FDA Aseptic Guide: Bridging Compliance
EU and U.S. regulators share the same sterility assurance goals, but their approaches differ. Learn how to align Annex 1 and FDA guidance to streamline ...
Read More
Blog GMP & GDP: Ensuring Quality in Drug Storage and Transport
Storage and transport aren’t just logistics — they’re critical GMP processes. Discover how USP helps pharma companies manage risk and maintain quality across global ...
Read More
Blog Blockchain for GMP Documentation: Hype or Future Reality?
Blockchain promises immutability, traceability, and transparency for GMP documentation. But is it a compliance game-changer — or just hype?
Read More
Guide Is Your Insurance Policy Ready for the New EU Product Liability Directive?
The EU’s new Product Liability Directive (2024/2853) changes who can be held liable and what damages can be claimed. From software and data loss to ...
Read More
Article 100% Drug Tariffs in the U.S. – Impact on Pharma Supply Chains & Compliance
The U.S. has announced sweeping 100% tariffs on patented medicines, disrupting pharma supply chains and market access. Discover what this means for manufacturers — and ...
Read More
Blog Data Governance & AI in Pharma | Ensuring Trust & Compliance
In an age where AI promises transformation across pharma, success hinges on one factor: data you can trust. Explore how rigorous governance, quality control, and ...
Read More
